Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obstructive Lung Diseases

Free Subscription 18.05.2026 3 Allergy 1 Am J Med 1 Am J Respir Cell Mol Biol 4 Am J Respir Crit Care Med 5 Ann Allergy Asthma Immunol 2 Arch Bronconeumol 1 Can Respir J 3 Chest 2 Clin Exp Allergy 1 Eur Respir J 1 J Allergy Clin Immunol 1 J Asthma 1 J Investig Allergol Clin Immunol 3 Pediatr Allergy Immunol 4 PLoS One 2 Respir Res 1 Rev Mal Respir 5 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. GUNAYDIN FE, Marcassa G, Olivieri B, Senna G, et al
   Is Asthma Remission a New Achievable Goal? A Review of the Current Drug-Related Evidence and Predictors.
   Allergy. 2026 May 14. doi: 10.1111/all.70388.
   PubMed         Abstract available
   
   
2. PYUNG YJ, Kang N, Chun J, Yu K, et al
   Metabolite-Based Endotypes of Asthma Reveal Distinct Clinical Characteristics and Immune Cell Signatures.
   Allergy. 2026 May 13. doi: 10.1111/all.70385.
   PubMed         Abstract available
   
   
3. LEE PH, Yoon S, Lee C, Jang AS, et al
   Moesin, a Cytoskeletal-Associated Protein, Outperforms Candidate Biomarkers in Identifying Asthma Exacerbation.
   Allergy. 2026 May 11. doi: 10.1111/all.70389.
   PubMed        
   
   

   
   Am J Med

4. WU J, Zhao R, Ma Y, Chen Y, et al
   Examining Sleep Quality and Mortality Risks in COPD, Asthma, and Asthma-COPD Overlap Patients.
   Am J Med. 2026 May 11:S0002-9343(26)00378-5. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   

   
   Am J Respir Cell Mol Biol

5. BORKAR NA, Halayko AJ
   Pirfenidone for asthma? What to do when standard therapies fail.
   Am J Respir Cell Mol Biol. 2026 May 11:aanag103. doi: 10.1093.
   PubMed        
   
   

   
   Am J Respir Crit Care Med

6. HANSEN S, von Bulow A, Cooper A, Sandin P, et al
   From mild-to-moderate to severe asthma: Risk factors and patient profiles from the NORDSTAR cohort.
   Am J Respir Crit Care Med. 2026 May 14:aamag242. doi: 10.1093.
   PubMed         Abstract available
   
   
7. SCHWORER SA, Murano H, O'Neal WK, Randell SH, et al
   Reply to Sharma and Sharma: Parsing the Drivers of Bronchiolar Mucus Plugs in Severe Asthma.
   Am J Respir Crit Care Med. 2026 May 13:aamag202. doi: 10.1093.
   PubMed        
   
   
8. SHARMA P, Sharma P
   Parsing the Drivers of Bronchiolar Mucus Plugs in Severe Asthma.
   Am J Respir Crit Care Med. 2026 May 13:aamag201. doi: 10.1093.
   PubMed        
   
   
9. HANSEL NN, Putcha N, Woo H, Fawzy A, et al
   Motivational interviewing and air cleaners for smokers with COPD (MOVE): a randomized, double-blind, placebo-controlled trial.
   Am J Respir Crit Care Med. 2026;212:952-963.
   PubMed         Abstract available
   
   

   
   Ann Allergy Asthma Immunol

10. SHER ER, Golant A, de Bruin-Weller M, Carrascosa JM, et al
    Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic Comorbidities.
    Ann Allergy Asthma Immunol. 2025 Dec 21:S1081-1206(25)01389.
    PubMed         Abstract available
    
    
11. LIPWORTH B, Zambelli E, Agazzi R, Piraino A, et al
    Relative particle size and distribution of inhaled triple therapies.
    Ann Allergy Asthma Immunol. 2026;136:545-549.
    PubMed         Abstract available
    
    
12. SUTER P, Greig R, Lipworth BJ
    Bucher indirect treatment comparison of phase 3 trials with dupilumab and tezepelumab in chronic rhinosinusitis with nasal polyps.
    Ann Allergy Asthma Immunol. 2026;136:589-595.
    PubMed         Abstract available
    
    
13. OPPENHEIMER JJ
    What's new in the care of patients with asthma?
    Ann Allergy Asthma Immunol. 2026;136:501.
    PubMed        
    
    
14. LANZ MJ, Cespedes LH, Chartrand EM, Eisenlohr CP, et al
    Utility of Exhaled Nitric Oxide as a Potential Biomarker in Non-Asthmatics with Multiple Food Allergies.
    Ann Allergy Asthma Immunol. 2026 May 11:S1081-1206(26)00196.
    PubMed        
    
    

    
    Arch Bronconeumol

15. TIOTIU A, Guidos Fogelbach G, Chong-Neto HJ, Novakova P, et al
    Impact of Biologics Administered for Severe Asthma on T2-comorbidities: A Narrative Review.
    Arch Bronconeumol. 2026 Apr 24:S0300-2896(26)00150.
    PubMed         Abstract available
    
    
16. SORIANO JB, Lopez-Campos JL
    The World's Burden of Chronic Respiratory Disease: An Epidemiological Review of Asthma, COPD, Interstitial Lung Disease, and Smoking in the 21st Century.
    Arch Bronconeumol. 2026 Apr 23:S0300-2896(26)00151.
    PubMed         Abstract available
    
    

    
    Can Respir J

17. LIU F, Cui H, Mei Y, Li K, et al
    Multiomics Approach Identifies Novel Genetic Determinants and Therapeutic Targets for Asthma.
    Can Respir J. 2026;2026:e6447989.
    PubMed         Abstract available
    
    

    
    Chest

18. ALISMAIL A, Ireland K
    Accuracy and Clinical Reasoning in Asthma Care: Insights from 14 Large Language Models.
    Chest. 2026;169:1167-1168.
    PubMed        
    
    
19. SONG JH, Kim Y
    When Routine Becomes Risk: Proton Pump Inhibitors in COPD and Asthma.
    Chest. 2026;169:1157-1158.
    PubMed        
    
    
20. DEHONDT V, Van Vaerenbergh F, Verhamme K, Lahousse L, et al
    Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases.
    Chest. 2026;169:1218-1227.
    PubMed         Abstract available
    
    

    
    Clin Exp Allergy

21. OH J, Kim S, Yim Y, Woo S, et al
    The Economic Value of Reducing Asthma Mortality in 64 Countries, 2000-2022, With Projections up to 2040: A Global Modelling Study.
    Clin Exp Allergy. 2026 May 12. doi: 10.1111/cea.70337.
    PubMed        
    
    
22. KRISHNA MT, Moitra S, Freeman A, Ainsworth B, et al
    Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income Countries.
    Clin Exp Allergy. 2026 May 15. doi: 10.1111/cea.70329.
    PubMed         Abstract available
    
    

    
    Eur Respir J

23. HU S, Shen X, Wang J, Lu H, et al
    Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis.
    Eur Respir J. 2026 May 14:2502796. doi: 10.1183/13993003.02796-2025.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

24. SETHI GS, Croft M
    CXCL16 as a Potential Therapeutic Target to Limit the Activity of Asthmatic CD4 Memory T cells.
    J Allergy Clin Immunol. 2026 May 13:S0091-6749(26)00340.
    PubMed         Abstract available
    
    

    
    J Asthma

25. LIU Y, Cheng L, Wang L
    Circulating IL-6 Associates with a Distinct Pediatric Asthma Subtype and Serves as a Potential Key Predictor for Risk Stratification.
    J Asthma. 2026 May 13:1-19. doi: 10.1080/02770903.2026.2666086.
    PubMed         Abstract available
    
    

    
    J Investig Allergol Clin Immunol

26. LEONHARDT J, Gaedtke L, Alkan GH, Hermann S, et al
    Eosinophilic Pleural Effusion Following Long-Term Asthma Remission Under Dupilumab Therapy: A Search for Clues Using Cytokine Analyses.
    J Investig Allergol Clin Immunol. 2026 May 13:0. doi: 10.18176/jiaci.1184.
    PubMed        
    
    

    
    Pediatr Allergy Immunol

27. RODRIGUES M, Henriques M, Santos S, Moreira P, et al
    Early childhood asthma and adiposity until adolescence: A prospective birth cohort study using body fat percentage.
    Pediatr Allergy Immunol. 2026;37:e70360.
    PubMed         Abstract available
    
    
28. PITT E, Fortnum K, Bourke M, Cairney J, et al
    Asthma and allergy prevalence among children at risk for developmental coordination disorder.
    Pediatr Allergy Immunol. 2026;37:e70370.
    PubMed        
    
    
29. YANG M, Srivastava U, Kho A, Tiwari A, et al
    MicroRNA clustering in pediatric asthma reveals differential corticosteroid responsiveness.
    Pediatr Allergy Immunol. 2026;37:e70374.
    PubMed         Abstract available
    
    

    
    PLoS One

30. SU S, Lin Y
    Identification of a diagnostic metabolomic fingerprint in plasma for eosinophilic granulomatosis with polyangiitis.
    PLoS One. 2026;21:e0343182.
    PubMed         Abstract available
    
    
31. CHOI SI, Jeong Y, Jung WJ, Kim BK, et al
    Usefulness of lung sound data collection using Skeeper SM-300(R) device: A pilot study.
    PLoS One. 2026;21:e0348588.
    PubMed         Abstract available
    
    
32. SHI C, Wang Y, Tan C, Zeng X, et al
    Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective.
    PLoS One. 2026;21:e0348955.
    PubMed         Abstract available
    
    
33. LEE TY, Petkau J, Johnson KM, Turvey SE, et al
    Development of an asthma policy model for Canada: Lifetime Exposures and Asthma outcomes Projection.
    PLoS One. 2026;21:e0348878.
    PubMed         Abstract available
    
    

    
    Respir Res

34. JOHANSSON MW, Esnault S, Floerke HL, Zhang J, et al
    Increased potential for atherogenic changes in asthma: evidence from transcriptomic studies of arterial endothelial cells.
    Respir Res. 2026 May 12. doi: 10.1186/s12931-026-03709.
    PubMed         Abstract available
    
    
35. OHRNEMAN H, Malinovschi A, Cai GH, Svartengren M, et al
    Aerosol deposition in the lung as a biomarker in asthma and chronic obstruction.
    Respir Res. 2026 May 11. doi: 10.1186/s12931-026-03706.
    PubMed         Abstract available
    
    

    
    Rev Mal Respir

36. FRISSON L, Reychler G
    [Indications and modalities of non-standard inhaled treatments for respiratory pathologies: A narrative review].
    Rev Mal Respir. 2026;43:34-48.
    PubMed         Abstract available
    
    

    
    Thorax

37. FARLEY C, Newman ANL, Phillips SM, Smith-Turchyn J, et al
    Measurement properties of the sit-to-stand test in community-dwelling people with chronic obstructive pulmonary disease: a COSMIN systematic review.
    Thorax. 2026;81:581-590.
    PubMed         Abstract available
    
    
38. BALASUBRAMANIAN A, Hemnes AR, Brittain EL, Annis J, et al
    Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD.
    Thorax. 2025 Nov 27:thorax-2025-223921. doi: 10.1136/thorax-2025-223921.
    PubMed         Abstract available
    
    
39. MATHIOUDAKIS AG, Bate S, Chatzimavridou-Grigoriadou V, Sivapalan P, et al
    Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial.
    Thorax. 2026;81:533-540.
    PubMed         Abstract available
    
    
40. SADATSAFAVI M, Miravitlles M, Quint JK, Perugini V, et al
    Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD.
    Thorax. 2026;81:541-547.
    PubMed         Abstract available
    
    
41. SHAW D, Pink K, McDowell PJ, Fardon T, et al
    Never say die: making a death from asthma a never event.
    Thorax. 2026 May 8:thorax-2025-224234. doi: 10.1136/thorax-2025-224234.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum